William G. Kaelin Jr.

Specialty: Hypoxia & Tumor Biology

Location: United States

Tier: ELITE

H-Index: 189

Years Active: 0

Hospital Affiliations

• Dana-Farber Cancer Institute - Faculty

Key Publications

1. "HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapy." - Cell (2025)
2. "The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins." - Science (2014)
3. "Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma." - Science (2018)
4. "Targeting the HIF2-VEGF axis in renal cell carcinoma." - Nat Med (2020)
5. "Positive selection CRISPR screens reveal a druggable pocket in an oligosaccharyltransferase required for inflammatory signaling to NF-κB." - Cell (2024)

Knowledge Graph Relationships

William G. Kaelin Jr. is a Hypoxia & Tumor Biology specialist affiliated with Dana-Farber Cancer Institute. Authored 5 scholarly articles.